Christophe Ginestier

18.9k citations

94 papers · 12.8k indexed · 7 hit papers · h-index 43

Impact in

Oncology top 0.1%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research

Papers in

Oncology 55
- Cancer Cells and Metastasis 38
- HER2/EGFR in Cancer Research 12
Cancer Research 28
- Cancer Genomics and Diagnostics 8
- Cancer, Hypoxia, and Metabolism 7

Co-authors: Emmanuelle Charafe‐Jauffret Max S. Wicha Daniel Birnbaum Gabriela Dontu Patrice Viens Suling Liu Jocelyne Jacquemier Florence Monville
Journals: Cancer Research (14 papers)Oncogene (8 papers)Clinical Cancer Research (3 papers)The Journal of Pathology (3 papers)International Journal of Oncology (3 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Christophe Ginestier

92 papers receiving 12.6k citations

Hit Papers

7 papers align trajectories log scale

Salinomycin kills cancer stem cells by sequestering iron in lysosomes 2017 · 465 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Nature Chemistry
2011 Cancer Research
2010 Journal of Clinical Investigation
2009 Cancer Research
2009 Cancer Research
2009 Clinical Cancer Research
2007 Cell stem cell

Peers

Countries citing papers authored by Christophe Ginestier

Since Specialization

Citations

This map shows the geographic impact of Christophe Ginestier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Ginestier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Ginestier more than expected).

Fields of papers citing papers by Christophe Ginestier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Ginestier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Ginestier. The network helps show where Christophe Ginestier may publish in the future.

Co-authors

The 25 scholars most cited alongside Christophe Ginestier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christophe Ginestier Line = papers co-authored together Christophe Ginestier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The interplay of DNA damage, epigenetics and tumour heterogeneity in driving cancer cell fitness Nature Communications ·Célia D. Rouault, Emmanuelle Charafe‐Jauffret, Christophe Ginestier	2025	0
2	A novel bioinformatic approach reveals cooperation between Cancer/Testis genes in basal-like breast tumors Oncogene ·Marthe Laisné, Brianna Rodgers, Sarah Benlamara, Julien Wicinski, Nicolás André, Lounes Djerroudi, Nikhil Gupta, Laure Ferry, Olivier Kirsh, Diana Daher, Claude Philippe, Yuki Okada, Emmanuelle Charafe‐Jauffret, Gaël Cristofari, Didier Meseure, Anne Vincent‐Salomon, Christophe Ginestier, Pierre‐Antoine Defossez	2024	1
3	Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin Cancers ·Jean Berthelet, Momeneh Foroutan, Dharmesh D. Bhuva, Holly J. Whitfield, Farrah El-Saafin, Joseph Cursons, Antonin Serrano, Michal Merdas, Elgene Lim, Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Matthias Ernst, Frédéric Hollande, Robin L. Anderson, Bhupinder Pal, Belinda Yeo, Melissa J. Davis, Delphine Mérino	2022	1
4	miRViz: a novel webserver application to visualize and interpret microRNA datasets Nucleic Acids Research ·Pierre Giroux, Ricky Bhajun, Stéphane Segard, Claire Picquenot, Céline Charavay, Lise Desquilles, Guillaume Pinna, Christophe Ginestier, Josiane Denis, Nadia Cherradi, Laurent Guyon	2020	9
5	Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer Journal of Clinical Medicine ·Renaud Sabatier, Emmanuelle Charafe‐Jauffret, Jean‐Yves Pierga, Hervé Curé, Éric Lambaudie, Dominique Genre, Gilles Houvenaeghel, Patrice Viens, Christophe Ginestier, François Bertucci, Patrick Sfumato, Jean-Marc Extra, Anthony Gonçalvès	2019	9
6	PH-domain-binding inhibitors of nucleotide exchange factor BRAG2 disrupt Arf GTPase signaling Nature Chemical Biology ·Agata Nawrotek, Sarah Benabdi, Supaporn Niyomchon, Marie-Hélène Kryszke, Christophe Ginestier, Tatiana Cañeque, Livia Tepshi, Angelica Mariani, Robert P. St.Onge, Guri Giaever, Corey Nislow, Emmanuelle Charafe‐Jauffret, Raphaël Rodriguez, Mahel Zeghouf, Jacqueline Cherfils	2019	24
7	Salinomycin kills cancer stem cells by sequestering iron in lysosomes Nature Chemistry ·Trang Thi, Ahmed Hamaï, Antje Hienzsch, Tatiana Cañeque, Sebastian Müller, Julien Wicinski, Olivier Cabaud, Christine Le Roy, Amandine David, Verónica Acevedo, Akihide Ryo, Christophe Ginestier, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Patrice Codogno, Maryam Mehrpour, Raphaël Rodriguez Hit paper breakdown →	2017	465
8	An iron hand over cancer stem cells Autophagy ·Ahmed Hamaï, Tatiana Cañeque, Sebastian Müller, Trang Thi, Antje Hienzsch, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Patrice Codogno, Maryam Mehrpour, Raphaël Rodriguez	2017	46
9	The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression Clinical Cancer Research ·Marion A. Salvador, Julien Wicinski, Olivier Cabaud, Yves Toiron, Pascal Finetti, Emmanuelle Josselin, Hélène Lelièvre, Laurence Kraus‐Berthier, Stéphane Depil, François Bertucci, Yves Collette, Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Christophe Ginestier	2013	113
10	Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity Cancer Research ·Ning Ning, Qin Pan, Fang Zheng, Seagal Teitz‐Tennenbaum, Martin Egenti, Ji Yet, Mu Li, Christophe Ginestier, Max S. Wicha, Jeffrey S. Moyer, Mark E. Prince, Yingxin Xu, Xiao-Lian Zhang, Shiang Huang, Alfred E. Chang, Qiao Li	2012	177
11	Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks Cancer Research ·Suling Liu, Christophe Ginestier, Sing J. Ou, Shawn G. Clouthier, Shivani Patel, Florence Monville, Hasan Körkaya, Amber Heath, Julie Dutcher, Celina G. Kleer, Younghun Jung, Gabriela Dontu, Russell S. Taichman, Max S. Wicha Hit paper breakdown →	2011	495
12	Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival Cancer Research ·Ines A. Silva, Shoumei Bai, Karen McLean, Kun Yang, Kent A. Griffith, Dafydd G. Thomas, Christophe Ginestier, Carolyn Johnston, Angela Kueck, R. Kevin Reynolds, Max S. Wicha, Ronald J. Buckanovich	2011	412
13	Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, Pascal Finetti, Min-Hee Hur, Mark E. Diebel, Florence Monville, Julie Dutcher, Marty Brown, Patrice Viens, Luc Xerri, François Bertucci, Giorgio Stassi, Gabriela Dontu, Daniel Birnbaum, Max S. Wicha Hit paper breakdown →	2009	935
14	Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer Clinical Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Flora Iovino, Carole Tarpin, Mark E. Diebel, Benjamin Esterni, Gilles Houvenaeghel, Jean-Marc Extra, François Bertucci, Jocelyne Jacquemier, Luc Xerri, Gabriela Dontu, Giorgio Stassi, Yi Xiao, Sanford H. Barsky, Daniel Birnbaum, Patrice Viens, Max S. Wicha Hit paper breakdown →	2009	575
15	BRCA1 regulates human mammary stem/progenitor cell fate Proceedings of the National Academy of Sciences ·Suling Liu, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, Hailey Foco, Celina G. Kleer, Sofía D. Merajver, Gabriela Dontu, Max S. Wicha	2008	336
16	ALDEFLUOR-positive populations in breast cell lines: evidence for cancer stem cells properties and gene expression profile (GEP) Cancer Research ·Emmanuelle Charafe‐Jauffret, Christophe Ginestier, Min Hee Hur, Florence Monville, Nathalie Cervera, Pascal Finetti, Julie Dutcher, Julien Wicinsky, M. M. Brown, Luc Xerri, François Bertucci, Daniel Birnbaum, Gabriela Dontu, Max S. Wicha	2007	1
17	Inflammatory breast cancers in Tunisia and France show similar immunophenotypes The Breast ·Emmanuelle Charafe‐Jauffret, Karima Mrad, Sana Intidhar Labidi‐Galy, Azza Ben Hamida, Khaled Ben Romdhane, Mansour Ben Abdallah, Christophe Ginestier, Benjamin Esterni, Daniel Birnbaum, Farhat Ben Ayed, Luc Xerri, Patrice Viens, Amel Mézlini, Jocelyne Jacquemier	2007	15
18	Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers Clinical Cancer Research ·Christophe Ginestier, Nathalie Cervera, Pascal Finetti, Séverine Esteyriès, Benjamin Esterni, José Adélaı̈de, Luc Xerri, Patrice Viens, Jocelyne Jacquemier, Emmanuelle Charafe‐Jauffret, Max Chaffanet, Daniel Birnbaum, François Bertucci	2006	107
19	Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis Cancer Research ·Jocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont, Valérie‐Jeanne Bardou, Emmanuelle Charafe‐Jauffret, Jeannine Geneix, José Adélaı̈de, Alane Koki, Gilles Houvenaeghel, J Hassoun, D Maraninchi, Patrice Viens, Daniel Birnbaum, François Bertucci	2005	174
20	A Recurrent Chromosome Breakpoint in Breast Cancer at the *NRG1* / *Neuregulin 1* / *Heregulin* Gene Cancer Research ·Huai-En Huang, Suet‐Feung Chin, Christophe Ginestier, Valérie‐Jeanne Bardou, José Adélaı̈de, N. Gopalakrishna Iyer, María J. García, Jessica C. Pole, Grace Callagy, Stephen M. Hewitt, William J. Gullick, Jocelyne Jacquemier, Carlos Caldas, Max Chaffanet, Daniel Birnbaum, Paul A. Edwards	2004	73

About Christophe Ginestier

Christophe Ginestier is a scholar working on Oncology, Cancer Research, Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 94 papers that have together received 12.8k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (38 papers), HER2/EGFR in Cancer Research (12 papers), Epigenetics and DNA Methylation (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Cancer Genomics and Diagnostics (8 papers), Genomics and Chromatin Dynamics (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Gene expression and cancer classification (7 papers). The work is most often cited by research in Oncology (8.2k citations), Cancer Research (4.3k citations), Molecular Biology (7.2k citations), Biotechnology (574 citations) and Cell Biology (948 citations). Christophe Ginestier has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Emmanuelle Charafe‐Jauffret, Max S. Wicha, Daniel Birnbaum, Gabriela Dontu, Patrice Viens, Suling Liu, Jocelyne Jacquemier, Florence Monville, Julie Dutcher and Celina G. Kleer. Their work appears in journals such as Cancer Research, Oncogene, Clinical Cancer Research, The Journal of Pathology and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact